What to Watch as Pasqal’s SPAC Merger Heads to a Vote
Pasqal, the French neutral-atom quantum computing company, is going public via a SPAC merger with Bleichroeder Acquisition France Merger Sub 2 (BBCQ). The setup is attractive if you want exposure to a real commercial quantum platform, but shareholders should watch redemption risk, dilution, and whether the financing stack holds together.
Pasqal, the French neutral-atom quantum computing company, is going public via a SPAC merger with Bleichroeder Acquisition France Merger Sub 2 (BBCQ). The setup is attractive if you want exposure to a real commercial quantum platform, but shareholders should watch redemption risk, dilution, and whether the financing stack holds together.
Deal at a Glance
SPAC partner: Bleichroeder Acquisition France Merger Sub 2
SPAC ticker (trades now): BBCQ
Implied valuation: $2.0B EV
Expected close: late Q3 2026
Est. first trading date: late Q3 2026
Deal status: Announced
Source filing: SEC 425 (2026-07-10)
Company Overview
Pasqal is a neutral-atom quantum computing company founded in 2019 and headquartered in France. It says it delivers practical quantum computing at scale through a stack that includes on-premises quantum processing units, cloud access through its own platform and hyperscaler channels, and software tools designed to connect quantum workloads with classical compute. The company’s latest materials say it has 10 commercial QPUs total, including 7 installed or in the field and 3 more in production, plus 25+ commercial use cases and 40+ clients and partners.
Pasqal is positioning itself as a leader in the neutral-atom segment of a still-early quantum market. Its latest-generation machine uses 1,024 trapped atoms, and the company says it has 70+ PhDs, 85+ patents including pending patents, and a global team of more than 275 employees. The broader industry is still commercializing, with near-term demand centered on optimization, simulation, materials science, and hybrid CPU-GPU-QPU workflows rather than mass-market adoption.
The SPAC Deal
Pasqal is merging with Bleichroeder Acquisition France Merger Sub 2, with the SPAC currently trading as BBCQ. The transaction values Pasqal at $2.0 billion pre-money, with the investor deck showing a pro forma equity value of $2.6437 billion and a pro forma enterprise value of $1.9985 billion. For a company at this stage, that is a meaningful valuation and leaves investors leaning heavily on execution against a long-dated quantum roadmap.
The trust account was disclosed at $291.4 million cash-in-trust as of May 31, 2026, inclusive of deferred underwriting fees of up to $12.25 million. That trust is exposed to redemption risk, and the deck explicitly says the cash-in-trust and the $645.2 million cash-to-balance-sheet figure assume no redemptions. Pasqal also disclosed $250 million of committed convertible financing to purchase $312.5 million aggregate principal amount of senior unsecured convertible bonds and investment warrants. The materials show illustrative ownership of 11% for Bleichroeder shareholders, 3% for the sponsor, and 10% for convertible investors, while also warning that the illustration does not include warrant exercise or share-based compensation dilution. Bleichroeder’s redeemable warrants are exercisable at $11.50 per share, which adds another overhang. The deal is in the SEC registration/proxy process, with the F-4 filed May 26, 2026 and declared effective on August 6, 2026. The company says the combined business is expected to trade on Nasdaq as Pasqal Holding SA. Based on the filing timeline, the first trading window is likely late Q3 2026, assuming approval and closing follow shortly after the vote and regulatory clearances.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The SPAC route gives Pasqal a faster path to public markets than a traditional IPO and lets it present forward projections and roadmap targets more directly in investor materials. That matters for a company still building out a capital-intensive technology platform, because the story is less about current earnings power and more about funding the next phase of hardware deployment, software commercialization, and scaling toward fault-tolerant systems.
The deal also brings in committed financing alongside the merger, which is important for a business that is still burning cash and investing ahead of revenue. Pasqal’s materials frame the public listing as a way to fund growth, expand commercial deployment, and support its roadmap toward 200+ logical qubits by end-2029.
Financial Highlights
Pasqal disclosed 2025 commercial revenue of €16.5 million, up from €3.5 million in 2024. That is strong top-line growth, but it is still early-stage revenue relative to the scale implied by the deal. The company also says booked and awarded business was €66 million+ as of March 2026, which suggests a growing commercial pipeline.
On profitability and cash use, Pasqal reported FY2025 cash burn of €35.1 million, narrowing about 30% from 2024. Total operating expenses were €76.1 million in 2025 versus €61.3 million in 2024. Cash stood at €120.1 million as of May 31, 2026, or $139.8 million in the deck’s conversion. Forward targets in the investor presentation are projections, not historical results, including the goal of 200+ logical qubits by end-2029.
Risk Factors
The biggest de-SPAC-specific risk is redemption pressure. If too many BBCQ shareholders redeem, the trust cash can shrink materially, and Pasqal’s own materials say the combined company may have insufficient cash to execute its business plan. That is the core issue investors should watch before the vote and through closing.
Dilution is another major issue. The deal includes redeemable warrants exercisable at $11.50, plus dilution from the sponsor, convertible investors, and any future share-based compensation. The financing package also may not close as expected or may not be enough on its own. Beyond the transaction mechanics, Pasqal faces a fast-moving global quantum market, dependence on strategic partners and suppliers, slower-than-expected industry adoption, and French foreign investment/state-influence considerations because quantum is a sensitive sector.
Comparable Public Companies
Pasqal’s closest public comps are other quantum computing names, especially IonQ (IONQ), Rigetti Computing (RGTI), D-Wave Quantum (QBTS), and Quantum Computing Inc. (QUBT). These stocks have generally traded as high-volatility, narrative-driven names rather than fundamentals-first businesses, with valuation tied more to platform potential, technical milestones, and commercial traction than near-term earnings.
That comp set is useful because it shows how the market prices early quantum commercialization: investors are paying for optionality, but they are also quick to punish dilution, weak execution, or financing uncertainty. Pasqal’s own materials emphasize that it is one of the larger pure-play neutral-atom platforms, but the public market will still compare it against peers that have already been through the de-SPAC process.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
The setup favors investors who want a direct public-market way to express a view on quantum computing, but the deal mechanics matter as much as the technology story. Pasqal has real commercial traction, a disclosed financing package, and a credible hardware/software platform, yet the valuation is already rich for a company with €16.5 million of 2025 revenue and ongoing cash burn. Shareholders should watch the redemption level, the final cash delivered at close, and whether the convertible financing lands as disclosed.
Why this matters now: the deal has moved through SEC effectiveness and is in the final stretch before a public debut, so the market is about to reprice Pasqal from private-growth narrative to listed-company scrutiny. If the trust holds up and the financing closes, the combined company could start trading in late Q3 2026 on Nasdaq under Pasqal Holding SA. If redemptions are heavy, the post-close balance sheet and the stock’s first-day setup could look very different from the headline valuation.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
